Owner Pfizer Inc. Abgenix, Inc.

Inventors Corvalan, Jose R.; Miller, Penelope E.; Cohen, Bruce D.; Gallo, Michael; Beebe, Jean; Moyer, James D.

Agent Cullen & Co

Pub. Number AU-B-2002231368

PCT Pub. Number WO2002/053596

Priority 60/259,927 05.01.01 US

Filing date 20 December 2001

Wipo publication date 16 July 2002

Acceptance publication date 23 November 2006

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids